Morgan Stanley Apyx Medical Corp Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Apyx Medical Corp stock. As of the latest transaction made, Morgan Stanley holds 15,457 shares of APYX stock, worth $23,185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,457
Previous 15,843
2.44%
Holding current value
$23,185
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding APYX
# of Institutions
48Shares Held
14.2MCall Options Held
17.8KPut Options Held
1.6K-
Nantahala Capital Management, LLC New Canaan, CT3.17MShares$4.75 Million0.25% of portfolio
-
Archon Capital Management LLC Seattle, WA3.14MShares$4.71 Million5.47% of portfolio
-
Royce & Associates LP2.62MShares$3.92 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$2.21 Million0.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT946KShares$1.42 Million100.0% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $51.9M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...